Victory Capital Management Inc Merrimack Pharmaceuticals Inc Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020
SELL
$2.21 - $3.88 $4,808 - $8,442
-2,176 Closed
0 $0
Q1 2020

May 04, 2020
SELL
$1.63 - $3.58 $79 - $175
-49 Reduced 2.2%
2,176 $5,000
Q4 2019

Feb 04, 2020
SELL
$3.15 - $4.67 $103 - $154
-33 Reduced 1.46%
2,225 $7,000
Q3 2019

Nov 12, 2019
BUY
$4.16 - $6.05 $9,393 - $13,660
2,258 New
2,258 $10,000

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email